The Eczema

Fucus Vesiculosus, Centella Asiatica, Aloe, Melissa Officinalis


Naples Soap Company
Human Otc Drug
NDC 69675-3273
The Eczema also known as Fucus Vesiculosus, Centella Asiatica, Aloe, Melissa Officinalis is a human otc drug labeled by 'Naples Soap Company'. National Drug Code (NDC) number for The Eczema is 69675-3273. This drug is available in dosage form of Soap. The names of the active, medicinal ingredients in The Eczema drug includes Aloe - 3 [hp_X]/g Centella Asiatica - 1 [hp_X]/g Fucus Vesiculosus - 1 [hp_X]/g Melissa Officinalis - 3 [hp_X]/g . The currest status of The Eczema drug is Active.

Drug Information:

Drug NDC: 69675-3273
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: The Eczema
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Fucus Vesiculosus, Centella Asiatica, Aloe, Melissa Officinalis
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Naples Soap Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Soap
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALOE - 3 [hp_X]/g
CENTELLA ASIATICA - 1 [hp_X]/g
FUCUS VESICULOSUS - 1 [hp_X]/g
MELISSA OFFICINALIS - 3 [hp_X]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 May, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Naples Soap Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0868521000004
UPC stands for Universal Product Code.
UNII:V5VD430YW9
7M867G6T1U
535G2ABX9M
YF70189L0N
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69675-3273-775 g in 1 PACKAGE (69675-3273-7)01 May, 2015N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Fucus vesiculosus - for eczema and psoriasis hydrocotyle asiatica - for acne, rosacea, and itching aloe - humectant melissa officinalis - reduces irritation; anti-bacterial/viral

Product Elements:

The eczema fucus vesiculosus, centella asiatica, aloe, melissa officinalis alcohol cow milk water glycerin sodium palmate sodium cocoate oatmeal coconut oil sodium chloride edetate sodium sodium citrate fucus vesiculosus fucus vesiculosus centella asiatica centella asiatica melissa officinalis melissa officinalis aloe aloe

Indications and Usage:

Uses: reduce and relieve itching and irritation due to: eczema psoriasis chronic dry skin

Warnings:

Warnings for external use only. if you are pregnant or breastfeeding, consult a physician first. if problem worsens or symptoms of allergic reaction occur, discontinue use and contact a physician for further evaluation of condition. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.

If swallowed, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions: use with water to create lather and wash the body, then rinse thoroughly. use twice dally for optimum results. safe for use on face, avoid contact with eyes

Stop Use:

If problem worsens or symptoms of allergic reaction occur, discontinue use and contact a physician for further evaluation of condition.

Package Label Principal Display Panel:

The eczema soap box

Further Questions:

Questions? 1-888-256-8265 or visit www.naplessoap.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.